s6 ribosomal protein cat Search Results


ribosomal protein s6 kinase (s6k) (cat. no. a4898)  (ABclonal Biotechnology)
90
ABclonal Biotechnology ribosomal protein s6 kinase (s6k) (cat. no. a4898)
HepG2 cells overexpressing USP10 were treated with PA (312.5 µM) for 24 h. Protein expression was assayed by western blotting. (A) Protein expression of tuberous sclerosis complex-2 (TSC2), mammalian target of rapamycin (mTOR), p-mTOR, ribosomal protein <t>S6</t> <t>kinase</t> <t>(S6K),</t> and p-S6K. Data are means±SD, n =3 (** p <0.01). (B) Expression of C-jun N-terminal protein kinase-1 (JNK1), VPS34, ATG14, Bcl2, and p-Bcl2. Data are means±SD, n =3 (* p <0.05; ** p <0.01; NS, not significant). ATG, autophagy target gene; JNK, C-jun N-terminal protein kinase; mTOR, mammalian target of rapamycin; S6K, ribosomal protein S6 kinase; TSC, tuberous sclerosis complex; USP, ubiquitin-specific peptidase; VPS34, phosphatidylinositol 3-kinase.
Ribosomal Protein S6 Kinase (S6k) (Cat. No. A4898), supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ribosomal protein s6 kinase (s6k) (cat. no. a4898)/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
ribosomal protein s6 kinase (s6k) (cat. no. a4898) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


HepG2 cells overexpressing USP10 were treated with PA (312.5 µM) for 24 h. Protein expression was assayed by western blotting. (A) Protein expression of tuberous sclerosis complex-2 (TSC2), mammalian target of rapamycin (mTOR), p-mTOR, ribosomal protein S6 kinase (S6K), and p-S6K. Data are means±SD, n =3 (** p <0.01). (B) Expression of C-jun N-terminal protein kinase-1 (JNK1), VPS34, ATG14, Bcl2, and p-Bcl2. Data are means±SD, n =3 (* p <0.05; ** p <0.01; NS, not significant). ATG, autophagy target gene; JNK, C-jun N-terminal protein kinase; mTOR, mammalian target of rapamycin; S6K, ribosomal protein S6 kinase; TSC, tuberous sclerosis complex; USP, ubiquitin-specific peptidase; VPS34, phosphatidylinositol 3-kinase.

Journal: Journal of Clinical and Translational Hepatology

Article Title: USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells

doi: 10.14218/JCTH.2022.00060

Figure Lengend Snippet: HepG2 cells overexpressing USP10 were treated with PA (312.5 µM) for 24 h. Protein expression was assayed by western blotting. (A) Protein expression of tuberous sclerosis complex-2 (TSC2), mammalian target of rapamycin (mTOR), p-mTOR, ribosomal protein S6 kinase (S6K), and p-S6K. Data are means±SD, n =3 (** p <0.01). (B) Expression of C-jun N-terminal protein kinase-1 (JNK1), VPS34, ATG14, Bcl2, and p-Bcl2. Data are means±SD, n =3 (* p <0.05; ** p <0.01; NS, not significant). ATG, autophagy target gene; JNK, C-jun N-terminal protein kinase; mTOR, mammalian target of rapamycin; S6K, ribosomal protein S6 kinase; TSC, tuberous sclerosis complex; USP, ubiquitin-specific peptidase; VPS34, phosphatidylinositol 3-kinase.

Article Snippet: Antibodies to ATG5 (cat. no. A0203), Beclin1 (cat. no. A11761), tuberous sclerosis complex (TSC)2 (cat. no. A19540), C-jun N-terminal protein kinase-1 (JNK1) (cat. no. A0288), phosphatidylinositol 3-kinase (VPS34) (cat. no. A12295), B-cell lymphoma 2 (Bcl2) (cat. no. A19693), p-Bcl2 at Ser70 (cat. no. AP0575), ribosomal protein S6 kinase (S6K) (cat. no. A4898), p-S6K at Thr389 (cat. no. AP1059) and p62 (cat. no. A7758) were provided by ABclonal (Woburn, MA, USA).

Techniques: Expressing, Western Blot